New Platform Streamlines Clinical Research Data
A new partnership automates data transfer for research sites, reducing administrative burdens in cancer studies.
Updated on Oct. 15, 2026 in Cancer
Live Poll
Do you believe automating clinical data entry will improve the quality of patient care?
IgniteData and RealTime eClinical Solutions have partnered to integrate their clinical data systems, aiming to streamline how information is shared during oncology trials. This collaboration allows research sites to transfer patient data directly to sponsor systems, potentially reducing administrative hurdles in cancer research.
Why it matters
By eliminating the need for manual data re-entry, this integration reduces the administrative burden on clinical coordinators at research sites. Improving data transfer efficiency can help accelerate the pace of clinical trials, ultimately bringing new treatments to patients faster.
This partnership leverages the Archer platform, currently used by 19 of the top 30 U.S. cancer centers, to link clinical research sites with sponsor databases. While the integration is live, the overall impact on trial timelines and site workload remains under observation.
The players
IgniteData
A health technology company specializing in automated data transfer platforms for clinical research.
RealTime eClinical Solutions
A provider of clinical research software, including Site Operations Management Systems, supporting over 3,000 global sites.
The details
The Archer platform automates the flow of information by connecting a clinical research site's existing electronic data system directly to a sponsor's electronic data capture (EDC) system. By enabling a single, electronic point of entry for patient information, the system removes the redundant and error-prone process of manually re-entering data into multiple portals. This automated transfer helps maintain data integrity across thousands of global research sites.
Timeline
October 15, 2026: The partnership between the two companies was announced.
Health Landscape
The clinical research field is increasingly focused on interoperability to solve systemic data-entry bottlenecks. The expansion of the Archer platform marks a shift toward digitized, automated site-to-sponsor communication in the modern oncology research environment.
While this technological update primarily affects research operations rather than individual care, it supports more efficient study conduct. Patients participating in clinical trials may benefit from reduced administrative delays, a topic worth discussing with a research coordinator.
The takeaway
The integration of digital platforms aims to reduce human error and speed up the processing of clinical trial data. Patients interested in how trial data affects their safety and enrollment should feel comfortable asking their study team about the data management systems used at their site.
Further reading
Learn more about the latest innovations in Cancer research and patient care.
Source note: This article includes information reported by BioXconomy.
Live Poll
Do you believe automating clinical data entry will improve the quality of patient care?
